Thursday's Health Winners & Losers

Bradley Pharmaceuticals (BDY Quote) tumbled after the biotech company's fourth-quarter profit fell short of Wall Street's expectations. The stock was losing $2.46, or 12.3%, to $17.48.

On the other hand, Bayer AG (BAY Quote) reported a fourth-quarter profit that exceeded expectations. The German drugmaker was recently up $1.15, or 2%, to $58.32.

Caremark (CMX Quote) rose 1.3% after CVS (CVS Quote) shareholders voted to approve the pending merger deal. CVS will acquire Caremark for $26.5 billion in cash and stock. CVS was also higher, adding 45 cents, or 1.4%, to $32.76.

Express Scripts (ESRX Quote), which had launched its own hostile bid for Caremark before getting rejected, was shedding 45 cents, or 0.6%, at $80.65.

Elsewhere, MedImmune (MEDI Quote) was gaining 1.5% at $31.35. Coventry Health Care (CVH Quote) was tacking on 1.2% at $55. Laboratory Corp. of America Holdings (LH Quote) was recently up 1.2% to $71.06.

Among decliners, Celgene (CELG Quote) was losing 2.5% at $50.86. St. Jude Medical (STJ Quote) was recently lower by 2.4% at $37.58. Amgen (AMGN Quote) was off 1% to $60.11.